Los Angeles Capital Management LLC Raises Holdings in Anika Therapeutics, Inc. (NASDAQ:ANIK)

Los Angeles Capital Management LLC boosted its position in Anika Therapeutics, Inc. (NASDAQ:ANIK) by 9.1% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 11,700 shares of the biotechnology company’s stock after purchasing an additional 980 shares during the period. Los Angeles Capital Management LLC’s holdings in Anika Therapeutics were worth $193,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently bought and sold shares of the company. HighTower Advisors LLC boosted its position in Anika Therapeutics by 11.3% in the 3rd quarter. HighTower Advisors LLC now owns 15,883 shares of the biotechnology company’s stock worth $387,000 after purchasing an additional 1,615 shares in the last quarter. R Squared Ltd acquired a new position in Anika Therapeutics in the 4th quarter valued at $27,000. Segall Bryant & Hamill LLC raised its stake in Anika Therapeutics by 1.7% in the 3rd quarter. Segall Bryant & Hamill LLC now owns 108,799 shares of the biotechnology company’s stock valued at $2,687,000 after purchasing an additional 1,794 shares during the last quarter. Quest Partners LLC increased its stake in shares of Anika Therapeutics by 115.8% in the 3rd quarter. Quest Partners LLC now owns 6,904 shares of the biotechnology company’s stock worth $171,000 after acquiring an additional 3,705 shares during the last quarter. Finally, FMR LLC increased its stake in shares of Anika Therapeutics by 25.3% in the 3rd quarter. FMR LLC now owns 24,721 shares of the biotechnology company’s stock worth $611,000 after acquiring an additional 4,996 shares during the last quarter. Hedge funds and other institutional investors own 91.53% of the company’s stock.

Anika Therapeutics Trading Up 1.0 %

NASDAQ ANIK opened at $17.03 on Thursday. The stock has a market cap of $249.42 million, a PE ratio of -2.56 and a beta of 0.89. Anika Therapeutics, Inc. has a twelve month low of $15.40 and a twelve month high of $29.11. The stock has a fifty day simple moving average of $16.89 and a 200-day simple moving average of $19.96.

Anika Therapeutics Profile

Anika Therapeutics, Inc, a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally.